Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 86

1.

The Value of Monitoring the Behavior of Circulating Tumor Cells at the End of Endocrine Therapy in Breast Cancer Patients.

Pachmann K, Schuster S.

Cancers (Basel). 2018 Oct 29;10(11). pii: E407. doi: 10.3390/cancers10110407.

2.

B7-H3 on circulating epithelial tumor cells correlates with the proliferation marker, Ki-67, and may be associated with the aggressiveness of tumors in breast cancer patients.

Pizon M, Schott DS, Pachmann U, Pachmann K.

Int J Oncol. 2018 Nov;53(5):2289-2299. doi: 10.3892/ijo.2018.4551. Epub 2018 Sep 4.

PMID:
30226585
3.

Circulating epithelial tumor cells as a prognostic tool for malignant melanoma.

Pachmann K, Willecke-Hochmuth R, Schneider K, Kaatz M.

Melanoma Res. 2018 Feb;28(1):37-43. doi: 10.1097/CMR.0000000000000407.

PMID:
29076925
4.
6.

The number of tumorspheres cultured from peripheral blood is a predictor for presence of metastasis in patients with breast cancer.

Pizon M, Schott D, Pachmann U, Pachmann K.

Oncotarget. 2016 Jul 26;7(30):48143-48154. doi: 10.18632/oncotarget.10174.

7.

Prognostic Role of Circulating Tumor Cells during Induction Chemotherapy Followed by Curative Surgery Combined with Postoperative Radiotherapy in Patients with Locally Advanced Oral and Oropharyngeal Squamous Cell Cancer.

Inhestern J, Oertel K, Stemmann V, Schmalenberg H, Dietz A, Rotter N, Veit J, Görner M, Sudhoff H, Junghanß C, Wittekindt C, Pachmann K, Guntinas-Lichius O.

PLoS One. 2015 Jul 17;10(7):e0132901. doi: 10.1371/journal.pone.0132901. eCollection 2015.

8.

Cancer cell classification with coherent diffraction imaging using an extreme ultraviolet radiation source.

Zürch M, Foertsch S, Matzas M, Pachmann K, Kuth R, Spielmann C.

J Med Imaging (Bellingham). 2014 Oct;1(3):031008. doi: 10.1117/1.JMI.1.3.031008. Epub 2014 Oct 3.

9.

[Circulating tumor cells in head and neck cancer].

Guntinas-Lichius O, Pachmann K.

Laryngorhinootologie. 2015 Jun;94(6):367-72. doi: 10.1055/s-0035-1548921. Epub 2015 Jun 3. Review. German.

PMID:
26039038
10.

Current and potential use of MAINTRAC method for cancer diagnosis and prediction of metastasis.

Pachmann K.

Expert Rev Mol Diagn. 2015 May;15(5):597-605. doi: 10.1586/14737159.2015.1032260. Epub 2015 Apr 5.

PMID:
25843106
11.

Determining tissue origin of circulating epithelial cells (CEC) in patients with differentiated thyroid cancer by real-time PCR using thyroid mRNA probes.

Sorg S, Pachmann K, Brede-Hekimian K, Freesmeyer M, Winkens T.

Cancer Lett. 2015 Jan 28;356(2 Pt B):491-5. doi: 10.1016/j.canlet.2014.09.046. Epub 2014 Oct 7.

PMID:
25304372
12.

The influence of radioiodine therapy on the number of circulating epithelial cells (CEC) in patients with differentiated thyroid carcinoma - a pilot study.

Winkens T, Pachmann K, Freesmeyer M.

Exp Clin Endocrinol Diabetes. 2014 Apr;122(4):246-53. doi: 10.1055/s-0034-1370921. Epub 2014 Apr 25.

PMID:
24771011
13.

Heterogeneity of circulating epithelial tumour cells from individual patients with respect to expression profiles and clonal growth (sphere formation) in breast cancer.

Pizon M, Zimon D, Carl S, Pachmann U, Pachmann K, Camara O.

Ecancermedicalscience. 2013 Aug 23;7:343. doi: 10.3332/ecancer.2013.343. eCollection 2013.

14.

Disseminated tumor cells: a clinical help or over-information?

Pachmann K.

Eur J Radiol. 2012 Sep;81 Suppl 1:S114-5. doi: 10.1016/S0720-048X(12)70047-5. No abstract available.

PMID:
23083553
15.
16.

Promising development from translational or perhaps anti-translational research in breast cancer.

Retsky M, Demicheli R, Hrushesky WJ, Forget P, De Kock M, Gukas I, Rogers RA, Baum M, Pachmann K, Vaidya JS.

Clin Transl Med. 2012 Aug 28;1(1):17. doi: 10.1186/2001-1326-1-17.

17.

Circulating epithelial cells in patients with thyroid carcinoma. Can they be identified in the blood?

Winkens T, Pachmann K, Freesmeyer M.

Nuklearmedizin. 2013;52(1):7-13. doi: 10.3413/Nukmed-0524-12-08. Epub 2012 Dec 19.

PMID:
23254889
18.

NSAID analgesic ketorolac used perioperatively may suppress early breast cancer relapse: particular relevance to triple negative subgroup.

Retsky M, Rogers R, Demicheli R, Hrushesky WJ, Gukas I, Vaidya JS, Baum M, Forget P, Dekock M, Pachmann K.

Breast Cancer Res Treat. 2012 Jul;134(2):881-8. doi: 10.1007/s10549-012-2094-5. Epub 2012 May 24.

PMID:
22622810
19.

Epithelial cell dissemination and readhesion: analysis of factors contributing to metastasis formation in breast cancer.

Hekimian K, Meisezahl S, Trompelt K, Rabenstein C, Pachmann K.

ISRN Oncol. 2012;2012:601810. doi: 10.5402/2012/601810. Epub 2012 Mar 12.

20.

Demasking of epithelial cell adhesion molecule (EpCAM) on circulating epithelial tumor cells by Tween®20 treatment in breast cancer patients.

Hekimian K, Stein EL, Pachmann U, Pachmann K.

Clin Chem Lab Med. 2012 Dec 7;50(4):701-8. doi: 10.1515/cclm.2011.812.

PMID:
22505561
21.

A study of Docetaxel-induced effects in MCF-7 cells by means of Raman microspectroscopy.

Hartmann K, Becker-Putsche M, Bocklitz T, Pachmann K, Niendorf A, Rösch P, Popp J.

Anal Bioanal Chem. 2012 May;403(3):745-53. doi: 10.1007/s00216-012-5887-9. Epub 2012 Mar 8.

22.

Efficacy control of therapy using circulating epithelial tumor cells (CETC) as "liquid biopsy": trastuzumab in HER2/neu-positive breast carcinoma.

Pachmann K, Camara O, Kroll T, Gajda M, Gellner AK, Wotschadlo J, Runnebaum IB.

J Cancer Res Clin Oncol. 2011 Sep;137(9):1317-27. doi: 10.1007/s00432-011-1000-6. Epub 2011 Jul 8.

23.

Assessing the efficacy of targeted therapy using circulating epithelial tumor cells (CETC): the example of SERM therapy monitoring as a unique tool to individualize therapy.

Pachmann K, Camara O, Kohlhase A, Rabenstein C, Kroll T, Runnebaum IB, Hoeffken K.

J Cancer Res Clin Oncol. 2011 May;137(5):821-8. doi: 10.1007/s00432-010-0942-4. Epub 2010 Aug 8.

24.

Monitoring circulating epithelial tumour cells (CETC) to gauge therapy: in patients with disease progression after trastuzumab persisting CETC can be eliminated by combined lapatinib treatment.

Camara O, Jörke C, Hammer U, Egbe A, Rabenstein C, Runnebaum IB, Hoeffken K, Pachmann K.

J Cancer Res Clin Oncol. 2009 Apr;135(4):643-7. doi: 10.1007/s00432-008-0498-8. Epub 2008 Oct 21.

PMID:
18936973
25.

Monitoring circulating epithelial tumor cells (CETCs) during primary systemic chemotherapy including trastuzumab for early prediction of outcome in patients with Her2/neu-positive tumors.

Gajda M, Camara O, Oppel S, Kroll T, Jörke C, Krauspe S, Hammer U, Rabenstein C, Untch M, Runnebaum IB, Pachmann K.

Ann Oncol. 2008 Dec;19(12):2090-1. doi: 10.1093/annonc/mdn648. Epub 2008 Sep 26. No abstract available.

26.

Circulating tumor cells in breast cancer: methodology and clinical repercussions.

Gasent Blesa JM, Alberola Candel V, Esteban González E, Vidal Martínez J, Gisbert Criado R, Provencio Pulla M, Laforga Canales J, Pachmann K.

Clin Transl Oncol. 2008 Jul;10(7):399-406. Review.

PMID:
18628068
27.

Monitoring the response of circulating epithelial tumor cells to adjuvant chemotherapy in breast cancer allows detection of patients at risk of early relapse.

Pachmann K, Camara O, Kavallaris A, Krauspe S, Malarski N, Gajda M, Kroll T, Jörke C, Hammer U, Altendorf-Hofmann A, Rabenstein C, Pachmann U, Runnebaum I, Höffken K.

J Clin Oncol. 2008 Mar 10;26(8):1208-15. doi: 10.1200/JCO.2007.13.6523.

PMID:
18323545
28.

The relevance of circulating epithelial tumor cells (CETC) for therapy monitoring during neoadjuvant (primary systemic) chemotherapy in breast cancer.

Camara O, Rengsberger M, Egbe A, Koch A, Gajda M, Hammer U, Jörke C, Rabenstein C, Untch M, Pachmann K.

Ann Oncol. 2007 Sep;18(9):1484-92.

PMID:
17761704
29.

An increase in cell number at completion of therapy may develop as an indicator of early relapse: quantification of circulating epithelial tumor cells (CETC) for monitoring of adjuvant therapy in breast cancer.

Pachmann K, Dengler R, Lobodasch K, Fröhlich F, Kroll T, Rengsberger M, Schubert R, Pachmann U.

J Cancer Res Clin Oncol. 2008 Jan;134(1):59-65. Epub 2007 Jul 5.

PMID:
17611779
30.

Quantification of circulating tumour cells for the monitoring of adjuvant therapy in breast cancer: an increase in cell number at completion of therapy is a predictor of early relapse.

Lobodasch K, Fröhlich F, Rengsberger M, Schubert R, Dengler R, Pachmann U, Pachmann K.

Breast. 2007 Apr;16(2):211-8. Epub 2007 Feb 8.

PMID:
17291754
31.

Treatment with granulocyte-colony stimulating factor in patients with acute myocardial infarction. Evidence for a stimulation of neovascularization and improvement of myocardial perfusion.

Kuethe F, Krack A, Fritzenwanger M, Herzau M, Opfermann T, Pachmann K, Sayer HG, Werner GS, Gottschild D, Figulla HR.

Pharmazie. 2006 Nov;61(11):957-61.

PMID:
17152990
32.

Seeding of epithelial cells into circulation during surgery for breast cancer: the fate of malignant and benign mobilized cells.

Camara O, Kavallaris A, Nöschel H, Rengsberger M, Jörke C, Pachmann K.

World J Surg Oncol. 2006 Sep 26;4:67.

33.

Differential interaction of magnetic nanoparticles with tumor cells and peripheral blood cells.

Clement JH, Schwalbe M, Buske N, Wagner K, Schnabelrauch M, Görnert P, Kliche KO, Pachmann K, Weitschies W, Höffken K.

J Cancer Res Clin Oncol. 2006 May;132(5):287-92. Epub 2006 Jan 24.

PMID:
16432758
34.

Quantification of the response of circulating epithelial cells to neodadjuvant treatment for breast cancer: a new tool for therapy monitoring.

Pachmann K, Camara O, Kavallaris A, Schneider U, Schünemann S, Höffken K.

Breast Cancer Res. 2005;7(6):R975-9. Epub 2005 Oct 4.

35.

Treatment with granulocyte colony-stimulating factor for mobilization of bone marrow cells in patients with acute myocardial infarction.

Kuethe F, Figulla HR, Herzau M, Voth M, Fritzenwanger M, Opfermann T, Pachmann K, Krack A, Sayer HG, Gottschild D, Werner GS.

Am Heart J. 2005 Jul;150(1):115.

PMID:
16086558
36.

Longtime recirculating tumor cells in breast cancer patients.

Pachmann K.

Clin Cancer Res. 2005 Aug 1;11(15):5657; author reply 5657-8. No abstract available.

37.

Standardized quantification of circulating peripheral tumor cells from lung and breast cancer.

Pachmann K, Clement JH, Schneider CP, Willen B, Camara O, Pachmann U, Höffken K.

Clin Chem Lab Med. 2005;43(6):617-27.

PMID:
16006258
38.
39.

Impact of early NK cell recovery on development of GvHD and CMV reactivation in dose-reduced regimen prior to allogeneic PBSCT.

Scholl S, Mügge LO, Issa MC, Kasper C, Pachmann K, Höffken K, Sayer HG.

Bone Marrow Transplant. 2005 Jan;35(2):183-90.

PMID:
15531897
40.
41.

Expression of bcr-abl mRNA in individual chronic myelogenous leukaemia cells as determined by in situ amplification.

Pachmann K, Zhao S, Schenk T, Kantarjian H, El-Naggar AK, Siciliano MJ, Guo JQ, Arlinghaus RB, Andreeff M.

Br J Haematol. 2001 Mar;112(3):749-59.

PMID:
11260080
42.

Complementary anchor PCR of rearranged variable T-cell receptor beta-chain cDNA regions.

Oduncu F, Krause G, Röhnisch T, Emmerich B, Pachmann K.

Biol Chem. 1997 Oct;378(10):1211-4. Review.

PMID:
9372194
43.

Applications of consensus polymerase chain reaction with subsequent electrophoretic distinction of amplificates.

Krause G, Oduncu F, Kaltstein A, Pusl T, Pachmann K, Gerzer R.

Electrophoresis. 1997 Jun;18(7):1098-102.

PMID:
9237562
44.

Insulin-like growth factor I is an independent coregulatory modulator of natural killer (NK) cell activity.

Auernhammer CJ, Feldmeier H, Nass R, Pachmann K, Strasburger CJ.

Endocrinology. 1996 Dec;137(12):5332-6.

PMID:
8940354
45.

Particulate ANP-sensitive guanylyl cyclase: induction in cultured human peripheral CD3+ mononuclear blood cells.

Heim JM, Knau B, Sturm C, Fricke H, Hartmann J, Pachmann K, Schmidt KN, Vollmar A, Gerzer R.

J Mol Med (Berl). 1996 Oct;74(10):629-35.

PMID:
8912184
46.

Detection of HIV provirus by in situ polymerase chain reaction.

Pachmann K.

N Engl J Med. 1992 Nov 19;327(21):1529-30. No abstract available.

PMID:
1406888
47.

Influence of OM-85 BV on different humoral and cellular immune defense mechanisms of the respiratory tract.

Emmerich B, Pachmann K, Milatovic D, Emslander HP.

Respiration. 1992;59 Suppl 3:19-23.

PMID:
1439235
48.

In situ amplification of single copy gene segments in individual cells by the polymerase chain reaction.

Spann W, Pachmann K, Zabnienska H, Pielmeier A, Emmerich B.

Infection. 1991 Jul-Aug;19(4):242-4.

PMID:
1917036
49.

Highly fluorochrome labeled gene probes for quantitative tracing of RNA in individual cells by in situ hybridization.

Pachmann K, Reinecke K, Emmerich B, Thiel E.

Bioconjug Chem. 1991 Jan-Feb;2(1):19-25.

PMID:
1715189
50.

Quantitation of mRNA for the beta-adrenoceptor gene in human mononuclear leucocytes by in situ hybridization with fluorochrome labeled cloned DNA.

Liebl B, Pachmann K, Römer U, Haen E, Hallek M, Emmerich B.

J Recept Res. 1991;11(1-4):473-82.

PMID:
1653348

Supplemental Content

Loading ...
Support Center